Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leonardo L. Rezende
Management of Low-Risk Patients With Thyroid Carcinoma and Detectable Thyroglobulin on T4 After Thyroidectomy and Ablation With Iodine-131
Arquivos Brasileiros de Endocrinologia & Metabologia
Related publications
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-Risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unne
Journal of Ultrasound in Medicine
Nuclear Medicine
Radiology
Ultrasound Technology
Radiological
Imaging
Medicine
Re-Ablation I-131 Activity Does Not Predict Treatment Success in Low- And Intermediate-Risk Patients With Differentiated Thyroid Carcinoma
Endocrine
76. Investigation of Thyroglobulin Level Befor and After Administration of Iodine-131
Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
Iodine-131 and Thyroid Function
Environmental Health Perspectives
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I131Remnant Ablation in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy
Journal of Thyroid Research
Endocrinology
Metabolism
Diabetes
Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy (TENIS Syndrome)
International Journal of Otolaryngology and Head & Neck Surgery
Erratum To: Postsurgical Diagnostic Evaluation of Patients With Differentiated Thyroid Carcinoma: Comparison of Ultrasound, Iodine-131 Scintigraphy and PET With Fluorine-18 Fluorodeoxyglucose
Radiologia Medica
Medicine
Nuclear Medicine
Radiology
Imaging
Iodine 131 Treatment for Differentiated Thyroid Carcinoma in Patients With End Stage Renal Failure: Dosimetric, Radiation Safety, and Practical Considerations
Hormones
Medicine
Endocrinology
Metabolism
Diabetes
RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma
Oncology Letters
Cancer Research
Oncology